Did Glacier Bank buy First Security Bank?
Glenmark Pharmaceuticals has not been bought out in its entirety, but it has engaged in strategic divestments to streamline its operations and focus on its core business. In 2024, the company completed the sale of its 75% stake in Glenmark Life Sciences (GLS) to Nirma for approximately ₹5,651 crore (roughly US$680 million). This move was intended to reduce debt and optimize capital allocation. While Glenmark remains an independent, publicly traded entity, such divestments are common in the pharmaceutical sector as companies seek to shed non-core assets, improve their balance sheets, and concentrate their resources on developing innovative drug pipelines and expanding their market presence in key therapeutic areas.